News
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor ...
Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025 Provided by PR Newswire Jul 8, 2025, 8:05:00 PM ...
Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025 Jul. 08, 2025 4:05 PM ET Tyra Biosciences, Inc. (TYRA) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback